The reason why I'm hesitant about the near-term of #Alnylam (and why they should use their market cap heft while it lasts) is that the list price of #AMVUTTRA is twice that of #ATTRUBY and #VYNDAQEL... not sure how that is sustainable.
0
0
0
0